Translated title of the contribution: Chemotherapy and immunotherapy for malignant gliomas

R. Knerich, V. Silvani, D. Adinolfi, G. Robustelli della Cuna, G. Spanu, P. Preti, R. Rodriguez y Baena

Research output: Contribution to journalArticle


Although in recent years great progress has been made in brain tumor chemotherapy, this therapeutic approach appears to be conditioned by a large number of problems such as cell kinetics, tumor growth modalities, and drug delivery. Therefore only a small number of drugs (BCNU, CCNU, streptozocin, and procarbazine) clearly demonstrate effectiveness against these tumors. Immunotherapy raises the same and other problems.

Translated title of the contributionChemotherapy and immunotherapy for malignant gliomas
Original languageItalian
Pages (from-to)1333-1340
Number of pages8
JournalMinerva Medica
Issue number21
Publication statusPublished - 1984

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Chemotherapy and immunotherapy for malignant gliomas'. Together they form a unique fingerprint.

  • Cite this

    Knerich, R., Silvani, V., Adinolfi, D., Robustelli della Cuna, G., Spanu, G., Preti, P., & Rodriguez y Baena, R. (1984). CHEMIOTERAPIA ED IMMUNOTERAPIA DEI GLIOMI MALIGNI ENDOCRANICI. Minerva Medica, 75(21), 1333-1340.